Connection

Erin Michos to Proprotein Convertase 9

Back to Details
This is a "connection" page, showing publications Erin Michos has written about Proprotein Convertase 9.
Erin Michos
Connection Strength
0.043
Proprotein Convertase 9
  1. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.